H.C. Wainwright Reaffirms Buy on Balchem (BCPC), Lifts Price Target Following Strong Q2 Results

Balchem Corporation (NASDAQ:BCPC) ranks among the best mid-cap materials stocks to buy now. Following the company’s second-quarter financial reports, H.C. Wainwright maintained its Buy rating on Balchem Corporation (NASDAQ:BCPC) and increased its price target from $180 to $189 on August 5.

For the second quarter of 2025, Balchem Corporation (NASDAQ:BCPC) recorded revenue of $255.5 million, which was marginally higher than the $250.5 million reported in the first quarter and up 1% year-over-year. In contrast to H.C. Wainwright’s prediction of $1.09 per diluted share, the company’s GAAP net earnings came in at $1.17 per diluted share.

The Animal Health and Nutrition segment’s sales were about $56 million, somewhat lower than expected, while Specialty Products sales came in at $37.2 million, higher than expected. Meanwhile, the Industrial Products segment generated $1.48 million in revenue, which fell short of expectations.

Balchem Corporation (NASDAQ:BCPC) manufactures, produces, and distributes specialty performance ingredients and materials for a range of markets, including industrial, pharmaceutical, animal health, animal nutrition, medical device sterilization, and nutritional.

While we acknowledge the potential of BCPC as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: 10 Best Magic Formula Stocks for 2025 and 10 Best Retirement Stocks to Buy According to Hedge Funds.

Disclosure: None. This article is originally published at Insider Monkey.